Epithelial protein lost in neoplasm (EPLIN): Beyond a tumor suppressor
The majority of cancer-related deaths are caused by tumor recurrence, metastasis and therapeutic resistance. During the late stages of tumor progression, multiple factors are involved, including the downregulation and/or loss of function of metastasis suppressors. Epithelial protein lost in neoplasm...
Main Author: | Daqing Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2017-06-01
|
Series: | Genes and Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352304217300259 |
Similar Items
-
Epithelial Protein Lost in Neoplasm, EPLIN, the Cellular and Molecular Prospects in Cancers
by: Jianyuan Zeng, et al.
Published: (2021-07-01) -
EPLIN Expression in Gastric Cancer and Impact on Prognosis and Chemoresistance
by: Wenjing Gong, et al.
Published: (2021-04-01) -
Early Events in Actin Cytoskeleton Dynamics and E-Cadherin-Mediated Cell-Cell Adhesion during Epithelial-Mesenchymal Transition
by: Irina Y. Zhitnyak, et al.
Published: (2020-02-01) -
Loss of Tumor Suppressor C9orf9 Promotes Metastasis in Colorectal Cancer
by: Erfei Chen, et al.
Published: (2023-02-01) -
EPLIN, a Putative Tumour Suppressor in Colorectal Cancer, Implications in Drug Resistance
by: Jianyuan Zeng, et al.
Published: (2022-12-01)